@FierceBiotech: Biden maps out a 'moonshot' approach to cancer with plans to 'break down silos' in R&D. More | Follow @FierceBiotech
@JohnCFierce: FDA slaps down BioMarin's Duchenne's drug as rival nears a moment of truth. News | Follow @JohnCFierce
@DamianFierce: "I made a point to talk to female guests," he said. More from Bloomberg | Follow @DamianFierce
> Bloomberg reports that J&J ($JNJ) chief Alex Gorsky plans to continue a strategy of acquiring early-stage treatments rather than switch to a megamerger approach. Story
> Ionis Pharmaceuticals, formerly Isis, has earned a $1.5 million milestone from GlaxoSmithKline after launching a Phase I study of the hep B drug IONIS-HBV-LRx. Release
Medical Device News
@FierceMedDev: Medical device sales reps scouting out new jobs in 2016: Report. More | Follow @FierceMedDev
@EmilyWFierce: Olympus, FDA implicated in Senate probe of duodenoscope devices. Report | Follow @EmilyWFierce
> Hospira pump business nears chopping block as Pfizer mulls potential sale: Bloomberg. More
> FDA makes increasing use of 'real-world' device data a strategic priority. Report
> JPM: Boston Sci updates on Watchman reimbursement, Synergy launch. Article
Pharma News
@FiercePharma: U.S.-based Certara creates drug developing consultancy in China. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: J&J will boost workforce at South Africa consumer meds plant after $18M upgrade. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: $GSK vaccines head Slaoui says the company's vax and pharma businesses need each other--aka, no break-up, please. Article | Follow @CarlyHFierce
> For its next pare-down move, Pfizer weighs sale of Hospira pump business: Bloomberg. More
> FTC stats show pharma backing off pay-for-delay deals after SCOTUS ruling. Report
> Pfizer expands consumer biz in China with Treerly supplements buy. Article
Pharma Manufacturing News
> U.K.'s Oxford BioMedica gets MHRA nod for new manufacturing facility. Item
> GSK turns to K+N for supplier logistics. News
> FDA finds issues with Walgreens' infusion compounding services. Report
> EMA says Spain has taken action against drugmaker for shortcomings. Story
> Bayer opens large China plant for traditional Chinese and Western OTC meds. Article
CRO News
> Evotec hits an R&D milestone with J&J in an ambitious Alzheimer's collaboration. News
> Eurofins buys Dutch drug-testing firm to pad its services. More
> AMRI signs a trio of deals in R&D, manufacturing and marketing. Report
> Catalent inks a $619M deal to help Roche develop targeted therapies. Article
Pharma Asia News
> China-focused CASI Pharmaceuticals gets Marqbio review by CFDA. Item
> China continues to find problems in drug production. Article
> In Japan, fast approvals, more R&D cash and price cuts ahead. Report
> Astellas, Medivation report successful enzalutamide mCRPC PhII data in Lancet. More
> Cipla says top 50 drugs in development could bring in $30B. Story